Quantitative Systematic Strategies LLC Alaunos Therapeutics, Inc. Transaction History

Quantitative Systematic Strategies LLC

  • $0
  • Q3 2022

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 09, 2021
SELL
$2.09 - $3.09 $33,149 - $49,010
-15,861 Closed
0 $0
Q3 2020

Nov 09, 2020
BUY
$2.39 - $3.43 $37,907 - $54,403
15,861 New
15,861 $40,000
Q1 2019

Apr 15, 2019
SELL
$2.0 - $4.4 $39,028 - $85,861
-19,514 Closed
0 $0
Q4 2018

Feb 12, 2019
SELL
$1.61 - $3.62 $33,650 - $75,661
-20,901 Reduced 51.72%
19,514 $36,000
Q3 2018

Nov 14, 2018
BUY
$2.26 - $3.27 $91,337 - $132,157
40,415 New
40,415 $129,000

Others Institutions Holding TCRT

# of Institutions
5
Shares Held
92.6K
Call Options Held
0
Put Options Held
0
View Full List

About Alaunos Therapeutics, Inc.

TCRT Quotes by TradingView
  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $536M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email